| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of Axitinib |
| Disease Entry |
ICD 11 |
Status |
REF |
| Renal cell carcinoma |
2C90
|
Approved |
[2] |
|
|
|
Axitinib Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Vascular endothelial growth factor receptor 2 (KDR)
|
TTUTJGQ
|
VGFR2_HUMAN
|
Modulator
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Axitinib Interacts with 2 DTP Molecule(s)
| DTP Name |
DTP ID |
UniProt ID |
Mode of Action |
REF |
|
P-glycoprotein 1 (ABCB1)
|
DTUGYRD
|
MDR1_HUMAN
|
Substrate
|
[6] |
|
Organic anion transporting polypeptide 1B1 (SLCO1B1)
|
DT3D8F0
|
SO1B1_HUMAN
|
Substrate
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Axitinib Interacts with 5 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DE4LYSA
|
CP3A4_HUMAN
|
Metabolism
|
[7] |
|
Cytochrome P450 1A2 (CYP1A2)
|
DEJGDUW
|
CP1A2_HUMAN
|
Metabolism
|
[7] |
|
UDP-glucuronosyltransferase 1A1 (UGT1A1)
|
DEYGVN4
|
UD11_HUMAN
|
Metabolism
|
[7] |
|
Cytochrome P450 3A5 (CYP3A5)
|
DEIBDNY
|
CP3A5_HUMAN
|
Metabolism
|
[7] |
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DEGTFWK
|
CP2CJ_HUMAN
|
Metabolism
|
[7] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Axitinib Interacts with 2 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Mitogen-activated protein kinase 3 (MAPK3)
|
OTCYKGKO
|
MK03_HUMAN
|
Decreases Phosphorylation
|
[8] |
|
Mitogen-activated protein kinase 1 (MAPK1)
|
OTH85PI5
|
MK01_HUMAN
|
Decreases Phosphorylation
|
[8] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Bosutinib |
| Disease Entry |
ICD 11 |
Status |
REF |
| Blast phase chronic myelogenous leukemia, BCR-ABL1 positive |
N.A.
|
Approved |
[3] |
| Breast cancer |
2C60-2C65
|
Approved |
[4] |
|
|
|
Bosutinib Interacts with 2 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Tyrosine-protein kinase ABL1 (ABL)
|
TT3PJMV
|
ABL1_HUMAN
|
Inhibitor
|
[9] |
|
Proto-oncogene c-Src (SRC)
|
TT6PKBN
|
SRC_HUMAN
|
Inhibitor
|
[9] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Bosutinib Interacts with 1 DTP Molecule(s)
| DTP Name |
DTP ID |
UniProt ID |
Mode of Action |
REF |
|
P-glycoprotein 1 (ABCB1)
|
DTUGYRD
|
MDR1_HUMAN
|
Substrate
|
[10] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Bosutinib Interacts with 1 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DE4LYSA
|
CP3A4_HUMAN
|
Metabolism
|
[11] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Bosutinib Interacts with 2 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Proto-oncogene tyrosine-protein kinase Src (SRC)
|
OTETYX40
|
SRC_HUMAN
|
Decreases Phosphorylation
|
[12] |
|
Catenin beta-1 (CTNNB1)
|
OTZ932A3
|
CTNB1_HUMAN
|
Decreases Phosphorylation
|
[12] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|